Antigen-binding molecule that specifically binds to BCMA, GPRC5d and CD3, as well as the pharmaceutical use thereof

TW202637602APending Publication Date: 2026-09-16JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145978
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-25
Filing Date
2025-11-25
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076518_001
    Figure TWG2TA001076518_001
  • Figure TWG2TA001076518_002
    Figure TWG2TA001076518_002
  • Figure TWG2TA001076518_003
    Figure TWG2TA001076518_003
Patent Text Reader

Abstract

The application relates to antigen-binding molecule that specifically binds to BCMA, GPRC5D and CD3, as well as the pharmaceutical use thereof. Specifically, the application relates to antigen-binding molecules that specifically bind to BCMA, GPRC5D and CD3, and pharmaceutical use thereof.
Need to check novelty before this filing date? Find Prior Art